• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脂肪酸结合蛋白 4 浓度降低与慢性血液透析患者的肌肉减少症有关。

Decreased serum fatty acid binding protein 4 concentrations are associated with sarcopenia in chronic hemodialysis patients.

机构信息

Division of Nephrology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.

Division of Nephrology, Department of Internal Medicine, Hsin-Jen Hospital, New Taipei City, Taiwan.

出版信息

Clin Chim Acta. 2018 Oct;485:113-118. doi: 10.1016/j.cca.2018.06.025. Epub 2018 Jun 21.

DOI:10.1016/j.cca.2018.06.025
PMID:29935964
Abstract

BACKGROUND

Fatty acid binding protein 4 (FABP4) is found to play a role in skeletal muscle homeostasis. Since the dysregulation of FABP4 and sarcopenia are both highly prevalent in patients on chronic hemodialysis (HD), the correlation between them remains unknown. We aimed to examine this relationship in a cross-sectional study.

METHODS

A total of 120 chronic HD patients were recruited, and whose skeletal muscle mass, handgrip strength, and gait speed were assessed and blood samples were obtained. We grouped these participants into sarcopenia (n = 20) and non-sarcopenia groups according to European Working Group on Sarcopenia in Older People criteria.

RESULTS

The sarcopenia group exhibited lower weight (P < 0.001), height (P = 0.019), waist circumference (P < 0.001), body mass index (P < 0.001), body fat mass (P = 0.004), and lower serum triglycerides (P = 0.009), creatinine (P < 0.001), phosphorus (P = 0.013), intact parathyroid hormone (P = 0.012), and FABP4 concentrations (P = 0.005), and higher malnutrition-inflammation scores (MIS) (P = 0.031), urea reduction rates (P < 0.001), and fractional clearance index for urea (Kt/V) values (P < 0.001). Serum FABP4 concentrations (odds ratio (OR): 0.98, 95% confidence interval (CI): 0.96-0.99, P = 0.043), body fat mass (OR: 0.86, 95% CI: 0.77-0.97, P = 0.013), MIS (OR: 6.90, 95% CI: 1.31-36.36, P = 0.023), and Kt/V (each increase of 0.1, OR: 2.15, 95% CI: 1.29-3.57, P = 0.003) were independent predictors of sarcopenia in chronic HD patients.

CONCLUSIONS

We delineated the association between serum FABP4 concentrations and sarcopenia in chronic HD patients.

摘要

背景

脂肪酸结合蛋白 4(FABP4)在骨骼肌稳态中发挥作用。由于 FABP4 失调和肌肉减少症在慢性血液透析(HD)患者中都非常普遍,因此它们之间的相关性尚不清楚。我们旨在通过横断面研究来检验这种关系。

方法

共招募了 120 名慢性 HD 患者,并评估了他们的骨骼肌量、握力和步态速度,并采集了血液样本。我们根据欧洲老年人肌肉减少症工作组的标准将这些参与者分为肌肉减少症(n=20)和非肌肉减少症组。

结果

肌肉减少症组的体重(P<0.001)、身高(P=0.019)、腰围(P<0.001)、体重指数(P<0.001)、体脂肪量(P=0.004)和血清三酸甘油酯(P=0.009)、肌酐(P<0.001)、磷(P=0.013)、完整甲状旁腺激素(P=0.012)和 FABP4 浓度(P=0.005)均较低,营养不良-炎症评分(MIS)(P=0.031)、尿素减少率(P<0.001)和尿素分数清除率指数(Kt/V)值(P<0.001)均较高。血清 FABP4 浓度(比值比(OR):0.98,95%置信区间(CI):0.96-0.99,P=0.043)、体脂肪量(OR:0.86,95%CI:0.77-0.97,P=0.013)、MIS(OR:6.90,95%CI:1.31-36.36,P=0.023)和 Kt/V(每次增加 0.1,OR:2.15,95%CI:1.29-3.57,P=0.003)是慢性 HD 患者肌肉减少症的独立预测因素。

结论

我们描绘了慢性 HD 患者血清 FABP4 浓度与肌肉减少症之间的关系。

相似文献

1
Decreased serum fatty acid binding protein 4 concentrations are associated with sarcopenia in chronic hemodialysis patients.血清脂肪酸结合蛋白 4 浓度降低与慢性血液透析患者的肌肉减少症有关。
Clin Chim Acta. 2018 Oct;485:113-118. doi: 10.1016/j.cca.2018.06.025. Epub 2018 Jun 21.
2
Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients.血管紧张素 II 受体阻断剂与慢性血液透析患者肌肉力量的保留有关。
BMC Nephrol. 2019 Feb 14;20(1):54. doi: 10.1186/s12882-019-1223-3.
3
Negative correlation between leptin serum levels and sarcopenia in hemodialysis patients.血液透析患者血清瘦素水平与肌肉减少症之间的负相关。
Int J Clin Exp Pathol. 2018 Mar 1;11(3):1715-1723. eCollection 2018.
4
Modified Creatinine Index and the Risk of Bone Fracture in Patients Undergoing Hemodialysis: The Q-Cohort Study.改良的肌酸酐指数与血液透析患者骨折风险:Q 队列研究。
Am J Kidney Dis. 2017 Aug;70(2):270-280. doi: 10.1053/j.ajkd.2017.01.052. Epub 2017 Apr 25.
5
The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients.肌肉减少症的诊断主要由血液透析患者的肌肉量驱动。
Clin Nutr. 2017 Dec;36(6):1654-1660. doi: 10.1016/j.clnu.2016.10.016. Epub 2016 Oct 22.
6
Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.肌肉减少症及其各项单独标准与接受血液透析患者的死亡率部分相关。
Kidney Int. 2017 Jul;92(1):238-247. doi: 10.1016/j.kint.2017.01.024. Epub 2017 Mar 17.
7
Impact of sarcopenia and its diagnostic criteria on hospitalization and mortality in chronic hemodialysis patients: A 3-year longitudinal study.肌肉减少症及其诊断标准对慢性血液透析患者住院和死亡的影响:一项 3 年纵向研究。
J Formos Med Assoc. 2020 Jul;119(7):1219-1229. doi: 10.1016/j.jfma.2019.10.020. Epub 2019 Nov 16.
8
Skeletal muscle loss is negatively associated with single-pool Kt/V and dialysis duration in hemodialysis patients.骨骼肌丢失与血液透析患者的单池Kt/V及透析时间呈负相关。
Ther Apher Dial. 2014 Dec;18(6):612-7. doi: 10.1111/1744-9987.12174. Epub 2014 Mar 27.
9
The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.血清脂肪细胞脂肪酸结合蛋白在代谢综合征发展中的作用独立于促炎细胞因子。
Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):525-32. doi: 10.1016/j.numecd.2010.09.008. Epub 2010 Dec 24.
10
[Frequency of sarcopenia, cachexia, and associated factors in patients with chronic kidney disease in dialysis treatment].[透析治疗的慢性肾脏病患者中肌肉减少症、恶病质及相关因素的发生率]
Nutr Hosp. 2020 Dec 16;37(6):1157-1165. doi: 10.20960/nh.02954.

引用本文的文献

1
Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor Agonists.靶向慢性肾脏病中的肌肉减少症:胰高血糖素样肽-1受体激动剂的新作用
Int J Mol Sci. 2025 Aug 21;26(16):8096. doi: 10.3390/ijms26168096.
2
Gender-specific sarcopenia screening in hemodialysis: insights from lower limb strength and physiological indicators.血液透析中特定性别的肌肉减少症筛查:来自下肢力量和生理指标的见解
BMC Nephrol. 2025 May 19;26(1):247. doi: 10.1186/s12882-025-04176-2.
3
Prevalence and severity of sarcopenia in patients on maintenance hemodialysis: a cross-sectional study.
维持性血液透析患者肌少症的患病率和严重程度:一项横断面研究。
BMC Nephrol. 2024 Oct 29;25(1):385. doi: 10.1186/s12882-024-03836-z.
4
Combined evaluation of Geriatric nutritional risk index and Neutrophil to lymphocyte ratio for predicting all-cause and cardiovascular mortality in hemodialysis patients.联合评估老年营养风险指数和中性粒细胞与淋巴细胞比值预测血液透析患者全因和心血管死亡率。
PLoS One. 2023 Jun 29;18(6):e0287696. doi: 10.1371/journal.pone.0287696. eCollection 2023.
5
Sarcopenia in chronic kidney disease: from bench to bedside.慢性肾脏病中的肌肉减少症:从基础到临床。
Korean J Intern Med. 2023 May;38(3):303-321. doi: 10.3904/kjim.2022.338. Epub 2023 Apr 20.
6
Use machine learning to help identify possible sarcopenia cases in maintenance hemodialysis patients.利用机器学习帮助识别维持性血液透析患者中可能的肌肉减少症病例。
BMC Nephrol. 2023 Feb 14;24(1):34. doi: 10.1186/s12882-023-03084-7.
7
Prevalence of Sarcopenia and Its Impact on Cardiovascular Events and Mortality among Dialysis Patients: A Systematic Review and Meta-Analysis.透析患者肌少症的患病率及其对心血管事件和死亡率的影响:系统评价和荟萃分析。
Nutrients. 2022 Sep 30;14(19):4077. doi: 10.3390/nu14194077.
8
Nutritional Status Association With Sarcopenia in Patients Undergoing Maintenance Hemodialysis Assessed by Nutritional Risk Index.通过营养风险指数评估维持性血液透析患者营养状况与肌肉减少症的关联
Front Nutr. 2022 May 13;9:896427. doi: 10.3389/fnut.2022.896427. eCollection 2022.
9
Association between Serum Adipocyte Fatty Acid Binding Protein Level and Endothelial Dysfunction in Chronic Hemodialysis Patients.慢性血液透析患者血清脂肪细胞脂肪酸结合蛋白水平与内皮功能障碍的关系
Life (Basel). 2022 Feb 20;12(2):316. doi: 10.3390/life12020316.
10
Study on the Clinical Implications of NLR and PLR for Diagnosing Frailty in Maintenance Hemodialysis Patients and Their Correlations with Patient Prognosis.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对维持性血液透析患者衰弱诊断的临床意义及其与患者预后的相关性研究。
J Healthc Eng. 2022 Jan 12;2022:1267200. doi: 10.1155/2022/1267200. eCollection 2022.